Weight Loss Sale

Digestive Disorders References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Anatomical Chart Company® 2002; Lippincott Williams & Wilkins.
  2. Howell, E. Enzyme Nutrition: The Food Enzyme Concept 1986. Twin Lakes, WI: Lotus Press.
  3. Percival, M. Nutritional Pearls, Volume 35 1985. East Rutherford, NJ: Avery.
  4. Schneider, M.U., Knoll-Ruzicka, M.L., Domschke, S., Heptner, G., Domschke, W. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microsphericpancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Hepatogastroenterology 1985 Apr; 32(2): 97-102.
  5. Rachman, B. Unique features and application of non-animal derived enzymes. Clin.Nutr. Insights 1997; 5(10): 1-4.
  6. FitzGerald, D.E., Frisch, E.P., Milliken, J.C. Relief of chronic arterial obstruction using intravenous brinase. A control study. Scand. J. Thorac. Cardiovasc. Surg. 1979; 13(3): 327-32.
  7. Kirchhoff, R. et al. Increase in choleresis by means of artichoke extract. Results of a randomized placebo-controlled double-blind study.Phytomedicine 1994; 1: 107.
  8. Kupke, D., von Sanden, H., Trinczek-Gartner, H. et al.An evaluation of the choleretic activity of a plant-based cholagogue. Z. Allg. Med. 1991; 67: 1046-58 (in German).
  9. Held C. Artischoke bei Gallenwegsdyskinesien: Workshop “Neue Aspekte zur Therapie mit Chloretika.” Kluvensiek. 1991; 2:9. Cited in Kraft K. Artichoke leaf extract—Recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. Phytomedicine. 1997; 4(4):369-378.
  10. Fintelmann, V. Antidyspeptic and lipid-lowering effects of artichoke leaf (Cynarascolymus) extract. Results of clinical studies into the efficacy and tolerance of Hepar-SL forte involving 553 patients. Z. Allg. Med. 1996; 72: 48 (in German).
  11. Prahoveanu E., Esanu V. Immunomodulation with natural products. I. Effect of an aqueous extract of Raphanussativusniger on experimental influenza infection in mice. Virologie 1987 Apr-Jun: 38(2): 115-20 (in French).
  12. Ivanovics, G., Horvath, S. Isolation and properties of raphanin, an antibacterial substance from radish seed.Proc. Soc. Exp. Biol. Med. 1947; 66: 625-31.
  13. Leyck, S., Dereu, N., Etschenberg, E., Ghyczy, M., Graf, E., Winkelmann, J., Parnham, M.J. Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyenephosphatidylcholine (Phospholipon 100). Eur. J. Pharmacol. 1985 Oct 29; 117(1): 35-42.
  14. Axon, A.T. Helicobacter pylori infection. J. Antimicrob. Chemother.1993 Jul; 32: 61-8.
  15. Wakabayashi, H. et al. Effect of Helicobacter pylori infection on gastric mucosal phospholipid contents and their fatty acid composition. J. Gastroenterol. Hepatol. 1998 Jun; 13(6): 566-71.
  16. Tso, P. et al. Role of biliary phosphatidylcholine in the absorption and transport of dietary triolein in the rat. Gastroenterology 1981; 80(1): 60-5.
  17. Richmond, B.L., Boileau, A.C., Zheng, S., Huggins, K.W., Granholm, N.A., Tso, P., Hui, D.Y. Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A(2)-deficient mice. Gastroenterology 2001 Apr; 120(5): 1193-1202.
  18. Mourelle, M. et al. Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. Gastroenterology 1996 Apr; 110(4): 1093-7.
  19. Gotz JM, van Kan CI, Verspaget HW, et al. Gastric mucosal superoxide dismutases in Helicobacter pylori infection.Gut. 1996 Apr;38(4):502-6.
  20. Gotz JM, Thio JL, Verspaget HW, et al. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut. 1997 May;40(5):591-6.
  21. Langmead L, Rampton DS. Review article: herbal treatment in gastrointestinal and liver disease—benefits and dangers. Aliment PharmacolTher. 2001 Sep;15(9):1239-52.
  22. Noguchi K, Kato K, Moriya T, et al. Analysis of cell damage in Helicobacter pylori-associated gastritis. Pathol Int. 2002 Feb;52(2):110-8.
  23. Sempertegui F, Diaz M, Mejia R, et al. Low concentrations of zinc in gastric mucosa are associated with increased severity of Helicobacter pylori-induced inflammation. Helicobacter. 2007 Feb;12(1):43-8.
  24. D’Souza RS, Dhume VG.Gastric cytoprotection.Indian J PhysiolPharmacol. 1991 Apr;35(2):88-98.
  25. Cho CH, Luk CT, Ogle CW. The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci. 1991;49(23):L189-94.
  26. Cho CH, Ogle CW. The pharmacological differences and similarities between stress- and ethanol-induced gastric mucosal damage. Life Sci. 1992;51(24):1833-42.
  27. Barrera JL, Verastegui E, Meneses A, et al. Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial. Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51.
  28. Matsuzaka M, Fukuda S, Takahashi I, et al. The decreasing burden of gastric cancer in Japan. Tohoku J Exp Med. 2007 Jul;212(3):207-19.
  29. Matsukura T, Tanaka H. Applicability of zinc complex of L-carnosine for medical use.Biochemistry (Mosc.). 2000 Jul;65(7):817-23.
  30. Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment PharmacolTher. 1999 Apr;13(4):483-7.
  31. Mahmood A, FitzGerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007 Feb;56(2):168-175.
  32. Zhang L, Ma J, Pan K, et al. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter. 2005 Apr;10(2):139-45.
  33. Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment PharmacolTher. 2006 Apr 15;23(8):1077-86.
  34. Olukoga A, Donaldson D. Liquorice and its health implications. J R Soc Health. 2000 Jun;120(2):83-9.
  35. Petry JJ, Hadley SK. Medicinal herbs: answers and advice, Part 2. HospPract (Minneap.). 2001 Aug 15;36(8):55-9.
  36. Khayyal MT, Seif-El-Nasr M, El-Ghazaly MA, et al. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity. Phytomedicine. 2006;13Suppl 5:56-66.
  37. Kim JK, Oh SM, Kwon HS, et al. Anti-inflammatory effect of roasted licorice extracts on lipopolysaccharide-induced inflammatory responses in murine macrophages. BiochemBiophys Res Commun. 2006 Jul 7;345(3):1215-23.
  38. O’Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005 Dec 21;11(47):7499-507.
  39. Fukai T, Marumo A, Kaitou K, et al. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002 Aug 9;71(12):1449-63.
  40. Krausse R, Bielenberg J, Blaschek W, Ullmann U.In vitro anti-Helicobacter pylori activity of Extractumliquiritiae, glycyrrhizin and its metabolites.J AntimicrobChemother. 2004 Jul;54(1):243-6.
  41. Aly AM, Al-Alousi L, Salem HA. Licorice: a possible anti-inflammatory and anti-ulcer drug. AAPS PharmSciTech. 2005;6(1):E74-E82.
  42. Baker ME. Licorice and enzymes other than 11 beta-hydroxysteroid dehydrogenase: an evolutionary perspective. Steroids. 1994 Feb;59(2):136-41.
  43. Anon. Picrorhizakurroa.Monograph.Altern Med Rev. 2001 Jun;6(3):319-21.
  44. Govindarajan R, Vijayakumar M, Rawat AK, Mehrotra S. Free radical scavenging potential of PicrorhizakurrooaRoyle ex Benth. Indian J Exp Biol. 2003 Aug;41(8):875-9.
  45. Chander R, Kapoor NK, Dhawan BN. Effect of picroliv on glutathione metabolism in liver and brain of Mastomysnatalensis infected with Plasmodium berghei. Indian J Exp Biol. 1992 Aug;30(8):711-4.
  46. Chander R, Singh K, Visen PK, Kapoor NK, Dhawan BN. Picroliv prevents oxidation in serum lipoprotein lipids of Mastomyscoucha infected with Plasmodium berghei. Indian J Exp Biol. 1998 Apr;36(4):371-4.
  47. Sun M, Fan HW, Ma HY, Zhu Q. Protective effect of total glucosides of Picrorhizascrophulariiflora against oxidative stress in glomerular mesangial cells induced by high glucose.Yao XueXueBao. 2007 Apr;42(4):381-5.
  48. Vaidya AB, Antarkar DS, Doshi JC, et al. Picrorhizakurroa (Kutaki) Royle ex Benth as a hepatoprotective agent–experimental & clinical studies. J Postgrad Med. 1996 Oct;42(4):105-8.
  49. Gupta A, Khajuria A, Singh J, et al. Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhizakurroa. IntImmunopharmacol. 2006 Oct;6(10):1543-9.
  50. Puri A, Saxena RP, Guru PY, et al. Immunostimulant Activity of Picroliv, the Iridoid Glycoside Fraction of Picrorhizakurroa, and its Protective Action against Leishmaniadonovani Infection in Hamsters1. Planta Med. 1992 Dec;58(6):528-32.
  51. Sharma ML, Rao CS, Duda PL. Immunostimulatory activity of Picrorhizakurroa leaf extract.J Ethnopharmacol. 1994 Feb;41(3):185-92.
  52. Smit HF, Kroes BH, van den Berg AJ, et al. Immunomodulatory and anti-inflammatory activity of Picrorhizascrophulariiflora. J Ethnopharmacol. 2000 Nov;73(1-2):101-9.
  53. Barbieri SS, Cavalca V, Eligini S, et al. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free RadicBiol Med. 2004 Jul 15;37(2):156-65.
  54. Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ. AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med. 2007;74.
  55. Zhang Y, DeWitt DL, Murugesan S, Nair MG. Novel lipid-peroxidation- and cyclooxygenase-inhibitory tannins from Picrorhizakurroa seeds. ChemBiodivers. 2004 Mar;1(3):426-41.
  56. Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998 Dec;3(6):410-21.
  57. Gaddipati JP, Mani H, Banaudha KK, et al. Picroliv modulates the expression of insulin-like growth factor (IGF)-I, IGF-II and IGF-I receptor during hypoxia in rats. Cell Mol Life Sci. 1999 Oct 15;56(3-4):348-55.
  58. Li P, Matsunaga K, Ohizumi Y. Nerve growth factor-potentiating compounds from PicrorhizaeRhizoma. Biol Pharm Bull. 2000 Jul;23(7):890-2.
  59. Singh AK, Sharma A, Warren J, et al. Picroliv accelerates epithelialization and angiogenesis in rat wounds. Planta Med. 2007 Mar;73(3):251-6.
  60. Ray A, Chaudhuri SR, Majumdar B, et al. Antioxidant Activity of Ethanol Extract of Rhizome of PicrorhizaKurraon Indomethacin Induced Gastric Ulcer During Healing. Indian J ClinBiochem. 2002; 17(2): 44-51.